Impact Factor: 2.129 (2015) Journal Ranking: 147/210 (Oncology, Source:Publisher) Circulation: Average abstract views 34,450 per month (Source:Publisher) Frequency: There are 30 issues per year Aims of the journal: Future Oncology provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats. It is also available online. Content: The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues, that confront us in a new era of cancer care. The journal includes news and views, literature awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. Topics addressed include: Biological processes involved in cancer and how new understanding will impact treatment Clinical implications and applications for new biomarkers Impact of molecular genetics on prevention, screening, diagnosis and treatment Integration of diagnostic and therapeutic approaches Profiles of new anticancer agents Selective and 'personalized' approaches Screening programs and methodology Readership: Readership statistics according to profession: 72% academic, 11% cooperate, 8% government, 7% hospital (Source:Publisher)   Editorial contacts: Editorial board information available here Manuscript Submission: Submit your manuscript here They accept unsolicited manuscripts for publication. They accept reviews, perspectives, special reports, research articles, editorials, priority paper evaulations, conference scenes, company profiles, drug evaluations and clinical trial commentaries. All review articles are subject to rigorous peer-review by indepedent experts. Those interested in submitting articles should contact the commissioning editor with a brief proposal and article outline. Articles can be submitted editorially to the commissioning editor and online. Other information: Guidelines for authors can be found here

AI law and tech news you need. Trusted by experts at General Motors, McKesson, Deutsche Bank, Vectara, Weber Shandwick, F7 Ventures, and more. Future Perfect. Know more.

Website, newsletter and podcast devoted to effective altruism, the practice of using empirical evidence to craft public policy and initiatives designed to benefit as many people as possible. Coverage includes global health and economic development; animal welfare and the impacts of factory farming; climate change; and other catastrophic risks that pose an existential threat to humanity.

Future plc covers Publishing Industry

Update: Does not wish to be reached by PRs Future Positive is a blog about creative businesses and projects from around the world. From a new gallery space in Buenos Aires to a pop-up restaurant in South London, at the heart of each of our projects, there are creative individuals who went against the tide of conformity and followed their instinct to try something unique. The blog posts are written by Jakub Michalski (Founder/Editor) and Igor Termenon (Managing Editor / Photo Editor). Entries in the Future Positive concentrate on creative projects, independent businesses, independent publishing, new magazines, fashion, lifestyle, design, photography. PR opportunities include: Events, product launches, product or service reviews, photo & film shoots. The team can be reached via email or their social media platforms where they are active.

Background and Format: Future Power Technology covers the global energy industry. It features a mixture of articles covering news, views, industry project updates and trends, power-technology.com provides senior technology staff and other purchasing decision-makers from the renewable energy sector to the emerging nuclear space. It is aimed at those in the energy sector. For advertising information contact magsales@nridigital.com. Circulation: Source: Publisher

Background and Format: Future Rail is a digital magazine that offers up-to-date rail industry news and analysis. Content includes special reports exploring the biggest topics in the industry, project updates, and interviews with industry insiders. It also covers transport policy, infrastructure projects, technology for all areas of railway construction and maintenance, passenger and freight operations, rolling stock and engines, as well as stations, ticketing and passenger services. It is aimed at decision-makers in the rail industry worldwide wanting up-to-date news and analysis. For advertising information see contact details at www.railway-technology.com/contact-us/#accordion2

Covers issues surrounding blind children as they grow from birth through college. Also provides resources and information for parents and teachers, as well as a positive philosophy about blindness.

Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs

Background and Format: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal's broad coverage includes all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are of relevance to human health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of medical science. All original research articles will be considered that are within the journal's scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: Research articles Preliminary communications Short communications Methodologies Trial design articles Trial results (including early-phase and negative studies) Reviews Perspectives Commentaries Audience and Readership: Scientists in the biotechnology field Deadline: Average lead time to online publication: 14-16 weeks Circulation: A circulation figure is not available. Distribution: The journal is distributed free of charge online Editorial contacts: The Editorial Board members can be viewed here  Manuscript submission: Instructions for authors and editorial guidelines can be viewed here Ad rates: For more information on advertising see here  Other Information: Future Science OA provides readers the rigorous publication standards and article production quality they expect from the Future Science Group, with all articles subject to review by a minimum of three independent experts. The journal follows a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination. Authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.